Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Ранг среди акций #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Цена акции
$59.98
Последняя синхронизация: 2024-12-13
Рыночная капитализация
$1.22B
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Longboard Pharmaceuticals, Inc. (LBPH)

Категория

EPS для Longboard Pharmaceuticals, Inc. (LBPH)
EPS по состоянию на September 2024 TTM: $-2.24
Согласно последним финансовым отчетам и цене акций Longboard Pharmaceuticals, Inc., текущий EPS компании (TTM) составляет $-2.24. В конце 2022 EPS компании составлял $-2.51, больше, чем показателю 2021 года, равному $-1.62.
История EPS компании Longboard Pharmaceuticals, Inc. с 2020 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) $-2.24 -6.28%
2023 $-2.39 -4.78%
2022 $-2.51 54.94%
2021 $-1.62 97.56%
2020 $-0.82 0.00%
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$17.32 -873.21%
US
$27.74 -1,338.39%
NL
$-5.29 136.16%
AU
$-7.98 256.25%
US
- -
CH